396
Participants
Start Date
October 8, 2024
Primary Completion Date
April 11, 2027
Study Completion Date
September 10, 2027
Scan with elastic scattering spectroscopy device to assess risk of malignancy
Elastic scattering spectroscopy device uses a spectrum of light reflectance to compare suspicious lesion signature to that of previously scanned lesions with known benign or malignant pathology
RECRUITING
West Clinical Research, Morehead City
RECRUITING
Velocity, New Smyrna Beach
Lead Sponsor
DermaSensor, Inc.
INDUSTRY